These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28616250)

  • 21. Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients.
    Zhou Z; Liu XQ; Zhang SQ; Qi XM; Zhang Q; Yard B; Wu YG
    Amino Acids; 2021 May; 53(5):687-700. PubMed ID: 33811534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions Among Non-Coding RNAs in Diabetic Nephropathy.
    Loganathan TS; Sulaiman SA; Abdul Murad NA; Shah SA; Abdul Gafor AH; Jamal R; Abdullah N
    Front Pharmacol; 2020; 11():191. PubMed ID: 32194418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Magnesium in Diabetic Nephropathy for Better Outcomes.
    Mamilla M; Yartha SGR; Tuli R; Konipineni S; Rayaprolu DT; Borgharkar G; Kalluru PKR; Thugu TR
    Cureus; 2023 Aug; 15(8):e43076. PubMed ID: 37692668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
    Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
    Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
    Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Diabetic Nephropathy: Novel Insights from microRNAs.
    Lanzaro F; Barlabà A; De Nigris A; Di Domenico F; Verde V; Miraglia Del Giudice E; Di Sessa A
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
    Thipsawat S
    Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
    Abdel-Tawab MS; Mohamed MG; Doudar NA; Rateb EE; Reyad HR; Elazeem NAA
    Mol Biol Rep; 2023 Dec; 50(12):9793-9803. PubMed ID: 37831346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers.
    Tu C; Wei L; Wang L; Tang Y
    Diabetes Metab Syndr Obes; 2022; 15():907-920. PubMed ID: 35359345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.
    Ali H; Abu-Farha M; Hammad MM; Devarajan S; Bahbahani Y; Al-Khairi I; Cherian P; Alsairafi Z; Vijayan V; Al-Mulla F; Attar AA; Abubaker J
    Front Endocrinol (Lausanne); 2022; 13():882700. PubMed ID: 35712247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
    Kishore L; Kaur N; Singh R
    Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.
    Fiseha T; Tamir Z
    Int J Nephrol; 2016; 2016():4647685. PubMed ID: 27293888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
    Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers for Diabetic Nephropathy with a Focus on Kidney Injury Molecule-1 (KIM-1).
    Khonsha F; Valilo M; Nejabati HR; Rahmati-Yamchi M; Mota A
    Curr Diabetes Rev; 2024; 20(1):e280323215071. PubMed ID: 36994981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.
    Chen S; Dong C; Qian X; Huang S; Feng Y; Ye X; Miao H; You Q; Lu Y; Ding D
    J Diabetes Complications; 2017 Mar; 31(3):569-576. PubMed ID: 28007334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular podocytes in diabetic renal disease.
    Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
    Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary RBP as an Independent Predictor of Renal Outcome in Diabetic Nephropathy.
    Cai F; Zhang L; Zhao P; Qiu F; Mukhtar AM; Ma Y; Chen J; Han F
    Dis Markers; 2022; 2022():9687868. PubMed ID: 36299825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.